Cargando…
P364: A PHASE II STUDY OF LOW-INTENSITY CHEMOTHERAPY (MINI-HYPER-CVD) AND PONATINIB FOLLOWED BY BLINATUMOMAB AND PONATINIB IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428448/ http://dx.doi.org/10.1097/01.HS9.0000968368.11720.1f |
| _version_ | 1785090471761018880 |
|---|---|
| author | Haddad, Fadi Jabbour, Elias Nasr, Lewis Short, Nicholas Macaron, Walid Nasnas, Cedric Zoghbi, Marianne Issa, Ghayas Yilmaz, Musa Daver, Naval Pemmaraju, Naveen Masarova, Lucia Ravandi, Farhad Jain, Nitin Deen, Wuliamatu Loiselle, Christopher Waller, Lourdes Banks, Glenda Garris, Rebecca Kantarjian, Hagop |
| author_facet | Haddad, Fadi Jabbour, Elias Nasr, Lewis Short, Nicholas Macaron, Walid Nasnas, Cedric Zoghbi, Marianne Issa, Ghayas Yilmaz, Musa Daver, Naval Pemmaraju, Naveen Masarova, Lucia Ravandi, Farhad Jain, Nitin Deen, Wuliamatu Loiselle, Christopher Waller, Lourdes Banks, Glenda Garris, Rebecca Kantarjian, Hagop |
| author_sort | Haddad, Fadi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428448 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284482023-08-17 P364: A PHASE II STUDY OF LOW-INTENSITY CHEMOTHERAPY (MINI-HYPER-CVD) AND PONATINIB FOLLOWED BY BLINATUMOMAB AND PONATINIB IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA Haddad, Fadi Jabbour, Elias Nasr, Lewis Short, Nicholas Macaron, Walid Nasnas, Cedric Zoghbi, Marianne Issa, Ghayas Yilmaz, Musa Daver, Naval Pemmaraju, Naveen Masarova, Lucia Ravandi, Farhad Jain, Nitin Deen, Wuliamatu Loiselle, Christopher Waller, Lourdes Banks, Glenda Garris, Rebecca Kantarjian, Hagop Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428448/ http://dx.doi.org/10.1097/01.HS9.0000968368.11720.1f Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Haddad, Fadi Jabbour, Elias Nasr, Lewis Short, Nicholas Macaron, Walid Nasnas, Cedric Zoghbi, Marianne Issa, Ghayas Yilmaz, Musa Daver, Naval Pemmaraju, Naveen Masarova, Lucia Ravandi, Farhad Jain, Nitin Deen, Wuliamatu Loiselle, Christopher Waller, Lourdes Banks, Glenda Garris, Rebecca Kantarjian, Hagop P364: A PHASE II STUDY OF LOW-INTENSITY CHEMOTHERAPY (MINI-HYPER-CVD) AND PONATINIB FOLLOWED BY BLINATUMOMAB AND PONATINIB IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA |
| title | P364: A PHASE II STUDY OF LOW-INTENSITY CHEMOTHERAPY (MINI-HYPER-CVD) AND PONATINIB FOLLOWED BY BLINATUMOMAB AND PONATINIB IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA |
| title_full | P364: A PHASE II STUDY OF LOW-INTENSITY CHEMOTHERAPY (MINI-HYPER-CVD) AND PONATINIB FOLLOWED BY BLINATUMOMAB AND PONATINIB IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA |
| title_fullStr | P364: A PHASE II STUDY OF LOW-INTENSITY CHEMOTHERAPY (MINI-HYPER-CVD) AND PONATINIB FOLLOWED BY BLINATUMOMAB AND PONATINIB IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA |
| title_full_unstemmed | P364: A PHASE II STUDY OF LOW-INTENSITY CHEMOTHERAPY (MINI-HYPER-CVD) AND PONATINIB FOLLOWED BY BLINATUMOMAB AND PONATINIB IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA |
| title_short | P364: A PHASE II STUDY OF LOW-INTENSITY CHEMOTHERAPY (MINI-HYPER-CVD) AND PONATINIB FOLLOWED BY BLINATUMOMAB AND PONATINIB IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA |
| title_sort | p364: a phase ii study of low-intensity chemotherapy (mini-hyper-cvd) and ponatinib followed by blinatumomab and ponatinib in patients with philadelphia chromosome-positive acute lymphoblastic leukemia |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428448/ http://dx.doi.org/10.1097/01.HS9.0000968368.11720.1f |
| work_keys_str_mv | AT haddadfadi p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT jabbourelias p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT nasrlewis p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT shortnicholas p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT macaronwalid p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT nasnascedric p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT zoghbimarianne p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT issaghayas p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT yilmazmusa p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT davernaval p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT pemmarajunaveen p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT masarovalucia p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT ravandifarhad p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT jainnitin p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT deenwuliamatu p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT loisellechristopher p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT wallerlourdes p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT banksglenda p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT garrisrebecca p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia AT kantarjianhagop p364aphaseiistudyoflowintensitychemotherapyminihypercvdandponatinibfollowedbyblinatumomabandponatinibinpatientswithphiladelphiachromosomepositiveacutelymphoblasticleukemia |